News
Mitotic rate makes comeback as melanoma prognosticator
Key insight: the relationship between mitotic rate and melanoma survival is nonlinear.
News
Improvements in chronic hand eczema seen with oral gusacitinib in phase 2 study
The rapidity of response was noteworthy in these steroid-refractory patients.
News
Tildrakizumab for psoriasis shows durable efficacy over 5 years
Few left long-term extension study because of adverse events or loss of efficacy.
News
Inattention to heightened CV risk common theme in clozapine deaths teaser
“Inadequate treatment for metabolic syndrome was found to be a mortality predictor while on clozapine therapy,” said Dr. Sharon Taub.
News
New-onset AFib common but unrecognized in the month after cardiac surgery
Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post...
News
Siblings of patients with bipolar disorder at increased risk
“Strategies to prevent onset of psychiatric illness in individuals with a first-generation family history ... should be lifelong,” said Dr. Lars...
News
Chronic inflammatory diseases vary widely in CHD risk
The highest coronary heart disease risks linked to inflammation are seen in SLE and systemic sclerosis, conditions that aren’t included in...
News
Clopidogrel bests ticagrelor head-to-head for elective PCI in ALPHEUS
Ticagrelor doesn’t reduce periprocedural myonecrosis, as hypothesized, but does cause more minor bleeding.
News
TIPS-3: Polypill provides meaningful primary cardiovascular prevention
“You’re seeing a paradigm shift right here in front of your eyes today. This could be a game changer in terms of preventing large numbers of...
News
What happened to melanoma care during COVID-19 sequestration
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News
Abrocitinib highly effective as long-term monotherapy in AD
JADE EXTEND study shows nearly 90% EASI-75 rate at 48 weeks.
News
Smartphones can differentiate bipolar from borderline personality disorder
“It doesn’t replace doctors, but clearly it can add to diagnostic accuracy,” said Dr. Kate E.A. Saunders.
News
Topical tapinarof effective in pivotal psoriasis trials
Efficacy was comparable with potent topical corticosteroids, but without the side-effects baggage.
News
Who’s at risk for depression on isotretinoin?
Large Scottish study concludes prior depressive history is the sole predictor.
News
PARTNER registry valve-in-valve outcomes reassuring at 5 years
“This information is changing our algorithm for how we initially make treatment decisions in our patients.” – Dr. Rebecca T. Hahn